PLC
ORMP icon

Peapod Lane Capital’s Oramed Pharmaceuticals ORMP Stock Holding History

Peapod Lane Capital’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-84,779
Closed -$191K – 60
2025
Q2 		$191K Sell
84,779
-167,445
-66% -$369K 0.19% 57
2025
Q1 		$540K Buy
252,224
+24,985
+11% +$57.6K 0.61% 51
2024
Q4 		$550K Buy
+227,239
New +$540K 0.55% 53

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
M
Murchinson Toronto, Ontario, Canada $249M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return